Clinical Trials Directory

Trials / Completed

CompletedNCT01091597

Pulmonary Vein (PV) Isolation Versus Box Isolation for the Treatment of Atrial Fibrillation

PV Isolation Versus Box Isolation for the Treatment of Atrial Fibrillation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Johns Hopkins University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Curative catheter ablation has been established as an effective therapeutic option for atrial fibrillation (AF) that is resistant to pharmacologic rhythm or rate control. However, standard ablative approaches targeting the pulmonary veins (PVs) are associated with a success rate as low as 40%. In a recent study, Kumagai et al. described a new approach of catheter ablation of AF isolating the posterior left atrium including all PVs (called Box Isolation). In Kumagai's study, 46 patients with symptomatic AF underwent box isolation. At 6 months follow up, 43 of 46 patients (93%) were arrhythmia free without antiarrhythmic drugs, with a single procedure success rate of 87% (40/46). This study provided new evidence supporting the hypothesis that the posterior wall is of high importance for the maintenance of AF. The aim of the investigators study is to determine the efficacy of two different approaches of catheter ablation (Standard PV Isolation vs. Box isolation) for the treatment of chronic AF.

Conditions

Interventions

TypeNameDescription
PROCEDUREusual PV ablationusual PV ablation, per above
PROCEDUREBox isolation of pulmonary veinsas above

Timeline

Start date
2007-06-01
Primary completion
2009-02-01
Completion
2009-02-01
First posted
2010-03-24
Last updated
2010-03-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01091597. Inclusion in this directory is not an endorsement.